Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regorafenib”

290 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 290 results

Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Early research (Phase 1)Ended earlyNCT02910843
What this trial is testing

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Swiss Cancer Institute 25
Early research (Phase 1)Ended earlyNCT01187615
What this trial is testing

Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 9
Not applicableStudy completedNCT01996969
What this trial is testing

Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Seoul National University Hospital 117
Testing effectiveness (Phase 2)Study completedNCT02584465
What this trial is testing

REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression

Who this might be right for
Ovarian Carcinoma
ARCAGY/ GINECO GROUP 68
Not applicableStudy completedNCT02175095
What this trial is testing

[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

Who this might be right for
Colorectal Cancer
Asan Medical Center 68
Testing effectiveness (Phase 2)Study completedNCT01929616
What this trial is testing

Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)

Who this might be right for
Advanced Chemorefractory Colorectal Adenocarcinoma
Jules Bordet Institute 141
Testing effectiveness (Phase 2)Ended earlyNCT02402036
What this trial is testing

A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
Georgetown University 10
Not applicableUnknownNCT04835324
What this trial is testing

Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study

Who this might be right for
Advanced Colorectal Cancer
Chinese Academy of Medical Sciences 650
Not applicableStudy completedNCT05942768
What this trial is testing

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Hunan Cancer Hospital 103
Not applicableStudy completedNCT02656524
What this trial is testing

Stivarga Real Life Evidence in Hungary

Who this might be right for
Colorectal Neoplasms
Bayer 400
Testing effectiveness (Phase 2)Temporarily pausedNCT07071961
What this trial is testing

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Who this might be right for
Colorectal CancerRegorafenibHigh Risk Patients
M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT01853319
What this trial is testing

Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy

Who this might be right for
Colorectal Neoplasms
Bayer 100
Early research (Phase 1)Study completedNCT01853046
What this trial is testing

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Who this might be right for
Neoplasms
Bayer 24
Testing effectiveness (Phase 2)UnknownNCT05933980
What this trial is testing

Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerLiver MetastasesMSS
Sun Yat-sen University 44
Early research (Phase 1)WithdrawnNCT02439723
What this trial is testing

Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients

Who this might be right for
Metastatic Solid MalignanciesLocally Advanced Solid Malignancies
AHS Cancer Control Alberta
Not applicableEnded earlyNCT03956940
What this trial is testing

Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib

Who this might be right for
Hepatocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 18
Testing effectiveness (Phase 2)Study completedNCT02023333
What this trial is testing

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 11
Post-approval studies (Phase 4)Study completedNCT03564938
What this trial is testing

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Who this might be right for
Metastatic Colorectal Cancer
Bayer 100
Early research (Phase 1)Study completedNCT02085148
What this trial is testing

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Who this might be right for
Pediatric Oncology
Bayer 62
Load More Results